Meritage Portfolio Management Amgen Inc Transaction History

Meritage Portfolio Management

$1.58 Billion
Q2 2024

A detailed history of Meritage Portfolio Management transactions in Amgen Inc stock. As of the latest transaction made, Meritage Portfolio Management holds 25,180 shares of AMGN stock, worth $7.96 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

25,180

Previous 25,490 1.22%

Holding current value

$7.96 Million

Previous $7.25 Million 8.56%

% of portfolio

0.5%

Previous 0.46%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$262.75 - $319.31 $81,452 - $98,986	-310 Reduced 1.22%	25,180 $7.87 Million
Q1 2024 Apr 29, 2024	SELL	$268.87 - $324.56 $444,173 - $536,173	-1,652 Reduced 6.09%	25,490 $7.25 Million
Q4 2023 Feb 02, 2024	BUY	$255.7 - $288.46 $379,458 - $428,074	1,484 Added 5.78%	27,142 $7.82 Million
Q3 2023 Oct 30, 2023	SELL	$218.65 - $271.46 $160,270 - $198,980	-733 Reduced 2.78%	25,658 $6.9 Million
Q2 2023 Jul 31, 2023	SELL	$214.27 - $253.37 $358,045 - $423,381	-1,671 Reduced 5.95%	26,391 $5.86 Million
Q1 2023 Apr 25, 2023	BUY	$225.79 - $275.2 $7,902 - $9,632	35 Added 0.12%	28,062 $6.78 Million
Q4 2022 Feb 01, 2023	SELL	$229.03 - $291.01 $70,541 - $89,631	-308 Reduced 1.09%	28,027 $7.36 Million
Q3 2022 Oct 25, 2022	SELL	$224.46 - $253.15 $218,848 - $246,821	-975 Reduced 3.33%	28,335 $6.39 Million
Q2 2022 Jul 25, 2022	BUY	$230.71 - $256.74 $6.76 Million - $7.53 Million	29,310 New	29,310 $7.13 Million
Q3 2021 Oct 26, 2021	SELL	$212.27 - $248.7 $2.33 Million - $2.72 Million	-10,955 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$233.58 - $259.14 $16,117 - $17,880	69 Added 0.63%	10,955 $2.67 Million
Q1 2021 Apr 27, 2021	BUY	$221.91 - $258.6 $2.42 Million - $2.82 Million	10,886 New	10,886 $2.71 Million
Q4 2020 Feb 03, 2021	SELL	$216.38 - $257.67 $1.94 Million - $2.31 Million	-8,961 Closed	0 $0
Q3 2020 Oct 26, 2020	SELL	$234.65 - $260.95 $193,586 - $215,283	-825 Reduced 8.43%	8,961 $2.28 Million
Q2 2020 Jul 27, 2020	SELL	$197.81 - $242.74 $199,788 - $245,167	-1,010 Reduced 9.36%	9,786 $2.31 Million
Q1 2020 Apr 27, 2020	SELL	$182.24 - $241.7 $6.03 Million - $8 Million	-33,096 Reduced 75.4%	10,796 $2.19 Million
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $27,813 - $35,750	-147 Reduced 0.33%	43,892 $10.6 Million
Q3 2019 Oct 25, 2019	BUY	$174.11 - $208.62 $4.45 Million - $5.33 Million	25,561 Added 138.33%	44,039 $8.52 Million
Q2 2019 Jul 30, 2019	BUY	$166.7 - $195.41 $3.08 Million - $3.61 Million	18,478 New	18,478 $3.41 Million
Q1 2019 Apr 25, 2019	SELL	$180.87 - $203.88 $7.78 Million - $8.77 Million	-42,995 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$178.4 - $208.25 $204,624 - $238,862	-1,147 Reduced 2.6%	42,995 $8.37 Million
Q3 2018 Oct 30, 2018	SELL	$185.29 - $208.89 $65,222 - $73,529	-352 Reduced 0.79%	44,142 $9.15 Million
Q2 2018 Jul 25, 2018	SELL	$166.05 - $186.51 $62,766 - $70,500	-378 Reduced 0.84%	44,494 $8.21 Million
Q1 2018 Apr 26, 2018	BUY	$169.43 - $198.0 $151,978 - $177,606	897 Added 2.04%	44,872 $7.65 Million
Q4 2017 Jan 29, 2018	SELL	$168.79 - $188.59 $117,477 - $131,258	-696 Reduced 1.56%	43,975 $7.65 Million
Q3 2017 Oct 16, 2017	BUY	$167.29 - $191.0 $7.47 Million - $8.53 Million	44,671	44,671 $8.33 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Portfolio Management with notifications on news.

Account

Meritage Portfolio Management Amgen Inc Transaction History